BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 16937283)

  • 1. Genetic prognostic index influences patient outcome for node-positive breast cancer.
    Asaka S; Fujimoto T; Akaishi J; Ogawa K; Onda M
    Surg Today; 2006; 36(9):793-801. PubMed ID: 16937283
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Postoperative prognosis of node-negative breast cancers predicted by gene-expression profiling on a cDNA microarray of 25,344 genes.
    Tsumagari K; Chijiiwa K; Nagai H; Makita M; Kasumi F; Akiyama F; Sakamoto G; Miki Y
    Breast Cancer; 2005; 12(3):166-77. PubMed ID: 16110286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene expression patterns as marker for 5-year postoperative prognosis of primary breast cancers.
    Onda M; Emi M; Nagai H; Nagahata T; Tsumagari K; Fujimoto T; Akiyama F; Sakamoto G; Makita M; Kasumi F; Miki Y; Tanaka T; Tsunoda T; Nakamura Y
    J Cancer Res Clin Oncol; 2004 Sep; 130(9):537-45. PubMed ID: 15235906
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A 38-gene expression signature to predict metastasis risk in node-positive breast cancer after systemic adjuvant chemotherapy: a genomic substudy of PACS01 clinical trial.
    Jézéquel P; Campone M; Roché H; Gouraud W; Charbonnel C; Ricolleau G; Magrangeas F; Minvielle S; Genève J; Martin AL; Bataille R; Campion L
    Breast Cancer Res Treat; 2009 Aug; 116(3):509-20. PubMed ID: 19020972
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship of clinical and pathologic response to neoadjuvant chemotherapy and outcome of locally advanced breast cancer.
    Gajdos C; Tartter PI; Estabrook A; Gistrak MA; Jaffer S; Bleiweiss IJ
    J Surg Oncol; 2002 May; 80(1):4-11. PubMed ID: 11967899
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differentially expressed genes between primary cancer and paired lymph node metastases predict clinical outcome of node-positive breast cancer patients.
    Feng Y; Sun B; Li X; Zhang L; Niu Y; Xiao C; Ning L; Fang Z; Wang Y; Zhang L; Cheng J; Zhang W; Hao X
    Breast Cancer Res Treat; 2007 Jul; 103(3):319-29. PubMed ID: 17123152
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular markers of breast axillary lymph node metastasis.
    Cavalli LR
    Expert Rev Mol Diagn; 2009 Jul; 9(5):441-54. PubMed ID: 19580429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Screening of differential expression genes between primary breast cancer and its lymph node metastasis using single primer amplification of cDNA for microarray].
    Hao XS; Feng YM; Zhang L; Li XQ; Niu Y; Xiao CH; Sun BC
    Zhonghua Yi Xue Za Zhi; 2005 Feb; 85(6):385-90. PubMed ID: 15854527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression profiling to predict postoperative prognosis for estrogen receptor-negative breast cancers by analysis of 25,344 genes on a cDNA microarray.
    Nagahata T; Onda M; Emi M; Nagai H; Tsumagari K; Fujimoto T; Hirano A; Sato T; Nishikawa K; Akiyama F; Sakamoto G; Kasumi F; Miki Y; Tanaka T; Tsunoda T
    Cancer Sci; 2004 Mar; 95(3):218-25. PubMed ID: 15016320
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A clinical prognostic prediction of lymph node-negative breast cancer by gene expression profiles.
    Jiang D; Zhao N
    J Cancer Res Clin Oncol; 2006 Sep; 132(9):579-87. PubMed ID: 16761122
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1,809 patients.
    Györffy B; Lanczky A; Eklund AC; Denkert C; Budczies J; Li Q; Szallasi Z
    Breast Cancer Res Treat; 2010 Oct; 123(3):725-31. PubMed ID: 20020197
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beyond lymph node staging: molecular predictors of outcome in breast cancer.
    Sheldon DG
    Surg Oncol Clin N Am; 2005 Jan; 14(1):69-84, vi. PubMed ID: 15542000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High expression of valosin-containing protein predicts poor prognosis in patients with breast carcinoma.
    Cui Y; Niu M; Zhang X; Zhong Z; Wang J; Pang D
    Tumour Biol; 2015 Dec; 36(12):9919-27. PubMed ID: 26168958
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A prognostic model for lymph node-negative breast cancer patients based on the integration of proliferation and immunity.
    Oh E; Choi YL; Park T; Lee S; Nam SJ; Shin YK
    Breast Cancer Res Treat; 2012 Apr; 132(2):499-509. PubMed ID: 21667120
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Axillary lymph drainage as a prognostic factor of survival in breast cancer.
    Kett K; Szilágyi K; Anga B; Kett AG; Királyfalvi K
    Lymphology; 2002 Dec; 35(4):161-70. PubMed ID: 12570325
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Identification of the differentially expressed genes between primary breast cancer and paired lymph node metastasis through combining mRNA differential display and gene microarray].
    Feng YM; Gao G; Zhang F; Chen H; Wan YF; Li XQ
    Zhonghua Yi Xue Za Zhi; 2006 Oct; 86(39):2749-55. PubMed ID: 17199993
    [TBL] [Abstract][Full Text] [Related]  

  • 17. No common denominator for breast cancer lymph node metastasis.
    Weigelt B; Wessels LF; Bosma AJ; Glas AM; Nuyten DS; He YD; Dai H; Peterse JL; van't Veer LJ
    Br J Cancer; 2005 Oct; 93(8):924-32. PubMed ID: 16189523
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between Lymph Node Ratio and Disease Specific Survival in Breast Cancer Patients with One or Two Positive Lymph Nodes Stratified by Different Local Treatment Modalities.
    Hong R; Dai Z; Zhu W; Xu B
    PLoS One; 2015; 10(10):e0138908. PubMed ID: 26513258
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence and prognostic significance of complete axillary downstaging after primary chemotherapy in breast cancer patients with T1 to T3 tumors and cytologically proven axillary metastatic lymph nodes.
    Rouzier R; Extra JM; Klijanienko J; Falcou MC; Asselain B; Vincent-Salomon A; Vielh P; Bourstyn E
    J Clin Oncol; 2002 Mar; 20(5):1304-10. PubMed ID: 11870173
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aberrant expression of δ-like ligand 4 contributes significantly to axillary lymph node metastasis and predicts postoperative outcome in breast cancer.
    Xiao M; Yang S; Ning X; Huang Y
    Hum Pathol; 2014 Nov; 45(11):2302-10. PubMed ID: 25260720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.